Performant Healthcare (PHLT) Stock Price, News & Analysis

Company Overview

Performant Healthcare, Inc. engages in the provision of technology-enabled audit, recovery, customer care, and related analytics services. Its services help identify improper payments, and in some markets, restructure and recover delinquent or defaulted assets and improper payments for both government and private clients. The company was founded in 1976 and is headquartered in Plantation, FL.

Key Stats

• Today's Range: $7.61 to $7.62
• 50-Day Range: $3.00 to $7.64
• 52-Week Range: $2.17 to $7.74
• Volume: 927,939 shs
• Average Volume: 1.71 million shs
• Market Capitalization: $601.19 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $7.88
• Consensus Rating: Hold

Performant Healthcare Stock Analysis - MarketRank™

Performant Healthcare scored higher than 29% of companies evaluated by MarketBeat, and ranked 816th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.1 / 5
• Analyst Rating: Hold

Consensus Rating

Performant Healthcare has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 1 buy rating, 4 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Performant Healthcare has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Performant Healthcare are expected to grow in the coming year, from ($0.13) to ($0.06) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Performant Healthcare is -95.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Performant Healthcare is -95.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Performant Healthcare has a P/B Ratio of 7.32. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for PHLT.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Performant Healthcare does not currently pay a dividend.

Dividend Growth

Performant Healthcare does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for PHLT.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 0.29

News Sentiment

Performant Healthcare has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for Performant Healthcare this week, compared to 2 articles on an average week.

Search Interest

1 people have searched for PHLT on MarketBeat in the last 30 days.

MarketBeat Follows

1 people have added Performant Healthcare to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Performant Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $587,818.00 in company stock.

Percentage Held by Insiders

Only 9.10% of the stock of Performant Healthcare is held by insiders.

Percentage Held by Institutions

77.15% of the stock of Performant Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

PHLT Stock Analysis - Frequently Asked Questions

How have PHLT shares performed this year?

Performant Healthcare's stock was trading at $2.52 at the beginning of the year. Since then, PHLT stock has increased by 202.0% and is now trading at $7.61.

How were Performant Healthcare's earnings last quarter?

Performant Healthcare, Inc. (NASDAQ:PHLT) announced its quarterly earnings results on Thursday, May, 8th. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.02) by $0.04. The business earned $33.27 million during the quarter, compared to analysts' expectations of $29.92 million. Performant Healthcare had a negative trailing twelve-month return on equity of 0.04% and a negative net margin of 0.64%.

Who are Performant Healthcare's major shareholders?

Performant Healthcare's top institutional shareholders include Prescott Group Capital Management L.L.C. (20.17%), First Eagle Investment Management LLC (3.45%), Mirador Capital Partners LP (3.10%) and Geode Capital Management LLC (2.14%).
View institutional ownership trends.

How do I buy shares of Performant Healthcare?

Shares of PHLT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 5/08/2025
• Today: 8/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:PHLT
• Previous Symbol: NASDAQ:PHLT
• CIK: 1550695
• Web: www.performantcorp.com
• Phone: 925-960-4800
• Fax: 925-960-4880
• Employees: 930
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Performant Healthcare: $7.88
• High Price Target: $8.00
• Low Price Target: $7.75
• Potential Upside/Downside: +3.3%
• Consensus Rating: Hold
• Rating Score (0-4): 2.20
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.08)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$9.90 million
• Net Margins: -0.64%
• Pretax Margin: -0.63%
• Return on Equity: -0.04%
• Return on Assets: -0.03%

Debt

• Debt-to-Equity Ratio: 0.10
• Current Ratio: 2.64
• Quick Ratio: 2.64

Sales & Book Value

• Annual Sales: $122.98 million
• Price / Sales: 4.89
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.04 per share
• Price / Book: 7.33

Miscellaneous

• Outstanding Shares: 79,000,000
• Free Float: 71,808,000
• Market Cap: $601.98 million
• Optionable: N/A
• Beta: 0.41